• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1在促进注入安克洛酶或凝血酶的家兔纤维蛋白沉积中的作用。

Role of plasminogen activator inhibitor-1 in promoting fibrin deposition in rabbits infused with ancrod or thrombin.

作者信息

Krishnamurti C, Bolan C, Colleton C A, Reilly T M, Alving B M

机构信息

Department of Hematology, Walter Reed Army Institute of Research, Washington, DC 20307-5100.

出版信息

Blood. 1993 Dec 15;82(12):3631-6.

PMID:8260701
Abstract

The role of defective fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1-hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1, ancrod, or thrombin alone did not develop renal thrombi. All endotoxin-treated rabbits developed fibrin deposition when infused with ancrod (n = 4) or thrombin (n = 6). Fibrin deposition occurred in 7 of 7 rabbits receiving both rPAI-1 and ancrod and in only 1 of 6 receiving rPAI-1 and thrombin (P < .01). In vitro, thrombin but not ancrod was inactivated by normal rabbit plasma and by purified antithrombin III or thrombomodulin. The data indicate that elevated levels of PAI-1 promote fibrin deposition in rabbits infused with ancrod but not with thrombin. In endotoxin-treated rabbits, fibrin deposition that occurs with thrombin infusion may be caused by decreased inhibition of procoagulant activity and not increased PAI-1 activity.

摘要

纤溶酶原激活物抑制剂-1(PAI-1)活性升高导致的纤溶缺陷在促进体内纤维蛋白沉积中的作用尚未完全明确。本研究比较了凝血酶或安克洛酶(一种可使纤维蛋白原凝固的蛇毒衍生酶)在PAI-1水平升高的兔体内诱导纤维蛋白形成的效果。一组雄性新西兰兔静脉注射内毒素以增加内源性PAI-1活性,随后输注1小时的安克洛酶或凝血酶;另一组正常兔在输注安克洛酶或凝血酶期间静脉注射人重组PAI-1(rPAI-1)。输注结束30分钟后,通过组织病理学评估肾脏纤维蛋白沉积情况。单独接受内毒素、rPAI-1、安克洛酶或凝血酶的动物未形成肾血栓。所有接受内毒素治疗的兔在输注安克洛酶(n = 4)或凝血酶(n = 6)时均出现纤维蛋白沉积。接受rPAI-1和安克洛酶的7只兔中有7只出现纤维蛋白沉积,而接受rPAI-1和凝血酶的6只兔中只有1只出现(P <.01)。在体外,凝血酶可被正常兔血浆、纯化的抗凝血酶III或血栓调节蛋白灭活,而安克洛酶则不会。数据表明,PAI-1水平升高可促进输注安克洛酶的兔体内纤维蛋白沉积,但对输注凝血酶的兔则无此作用。在内毒素治疗的兔中,凝血酶输注时出现的纤维蛋白沉积可能是由于促凝活性抑制降低所致,而非PAI-1活性增加。

相似文献

1
Role of plasminogen activator inhibitor-1 in promoting fibrin deposition in rabbits infused with ancrod or thrombin.纤溶酶原激活物抑制剂-1在促进注入安克洛酶或凝血酶的家兔纤维蛋白沉积中的作用。
Blood. 1993 Dec 15;82(12):3631-6.
2
Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbits.纤溶酶原激活物抑制剂:兔体内抗栓酶诱导纤维蛋白沉积的调节因子
Blood. 1987 Mar;69(3):798-803.
3
Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.活化蛋白C对内毒素处理家兔组织型纤溶酶原激活剂诱导纤溶的增强作用
J Lab Clin Med. 1991 Dec;118(6):523-30.
4
PAI-1-resistant t-PA: low doses prevent fibrin deposition in rabbits with increased PAI-1 activity.
Blood. 1996 Jan 1;87(1):14-9.
5
Analysis of fibrin formation and proteolysis during intravenous administration of ancrod.静脉注射安克洛期间纤维蛋白形成及蛋白水解的分析
Blood. 2000 Oct 15;96(8):2793-802.
6
Plasminogen activation without changes in tPA and PAI-1 in response to subcutaneous administration of ancrod.皮下注射抗栓酶后,纤溶酶原激活,而组织型纤溶酶原激活物(tPA)和纤溶酶原激活物抑制剂-1(PAI-1)无变化。
Thromb Res. 2001 Dec 15;104(6):433-8. doi: 10.1016/s0049-3848(01)00391-7.
7
Thrombin infusion in endotoxin-treated rabbits reduces the plasma levels of plasminogen activator inhibitor: evidence for a protein-C-mediated mechanism.在内毒素处理的兔子中输注凝血酶可降低血浆纤溶酶原激活物抑制剂水平:蛋白C介导机制的证据。
Blood. 1989 Nov 1;74(6):1976-82.
8
Effects of recombinant plasminogen activator inhibitor type 1 on fibrinolysis in vitro and in vivo.
Thromb Res. 1990 Jul 15;59(2):309-17. doi: 10.1016/0049-3848(90)90133-w.
9
Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.缺氧协同诱导纤溶酶原激活物抑制剂-1(PAI-1)并抑制纤溶酶原激活物基因表达,从而促进肺血管纤维蛋白沉积。
J Clin Invest. 1998 Sep 1;102(5):919-28. doi: 10.1172/JCI307.
10
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.高度稳定的1型纤溶酶原激活物抑制剂(VLHL PAI-1)可保护纤维蛋白凝块免受组织纤溶酶原激活物介导的纤维蛋白溶解作用。
Int J Mol Med. 2007 Nov;20(5):683-7.

引用本文的文献

1
Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.抑肽酶事件的教训:心脏手术中抗纤维蛋白溶解治疗的现状观点。
J Anesth. 2010 Feb;24(1):96-106. doi: 10.1007/s00540-009-0866-9. Epub 2009 Dec 29.